Results 221 to 230 of about 221,275 (356)
Feasibility and safety of endoscopic ultrasound-guided liver biopsy to diagnose parenchymal liver disease: A multi-centre retrospective cohort study. [PDF]
Alali AA +8 more
europepmc +1 more source
In the real‐world VANESSA study in triple‐negative breast cancer, PD‐L1‐positive prevalence was 38% in early‐stage and 20% in metastatic tumours, lower than in prospective trials. The lower prevalence in smaller versus larger tissue samples and by local versus central assessment underlines the importance of robust PD‐L1 testing to determine eligibility
Corrado D'Arrigo +16 more
wiley +1 more source
Endoscopic Ultrasound-Guided Tissue Acquisition for Diagnosing Hepatic Malignant Lymphoma. [PDF]
Takano Y +5 more
europepmc +1 more source
Protein AG enables controlled antibody orientation on gold nanoparticles. Using side‐illumination darkfield microscopy, these immunoplasmonic nanoprobes can be quantified on cancer cells to measure protein expression, with results consistent with immunofluorescence.
Scott G. Harroun +4 more
wiley +1 more source
Intravitreal Bevacizumab plus Methotrexate for iris and ciliary body metastasis from lung cancer. [PDF]
Bastos TMA +6 more
europepmc +1 more source
Abstract Objectives The objective of this study is to compare the use of lymph node surgery and complication rates before and after centralization of penile cancer (PeCa) surgery in Sweden. In January 2015, curative surgical care for PeCa was centralized to the Skåne University Hospital in Malmö and the Örebro University Hospital in Örebro.
Åsa Warnolf +9 more
wiley +1 more source
Marine-Lenhart syndrome combined with papillary thyroid carcinoma: a case report. [PDF]
Zhuang Y, Lin W, Cai Q, Huang H.
europepmc +1 more source
This multicenter study of 827 thyroid nodules demonstrates that a targeted NGS 4‐gene panel (BRAF^V600E, TERT promoter, RET fusions, NTRK3 fusion) achieves high diagnostic accuracy (88.2%) and PPV (99.62%) for cytologically indeterminate Bethesda III–V nodules, offering a cost‐effective first‐line molecular test in China. ABSTRACT Molecular testing has
Qiong Jiao +8 more
wiley +1 more source

